Skip to main content
. 2017 Nov 6;37(6):BSR20171086. doi: 10.1042/BSR20171086

Figure 4. Immunohistochemistry staining results of the expression of CK7 and CK20 in lung cancer according to different clinical stages and grades.

Figure 4

(A) Expression of CK7 in different clinical stages and different grades of lung cancer, clinical stages were classified based on TNM criteria, covering three stages of stages I–III, respectively; different grades were categorized based on different differentiation status, including two grades of well (high-moderate) and poor (low); (B) Expression of CK20 in different clinical stages and different grades of lung cancer, clinical stages and grades were divided according to the above-mentioned criteria.